Anti inflammatory effects of Cannabis sativa L. seed oil in hemodialysis patients

Evaluation of the effects of Cannabis sativa L. seed oil on the serum concentration of interleukin 6 and interleukin 33 in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017031522637N3

Enrollment

130

Registered

2017-05-01

Start date

2017-03-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease (Hemodialysis). Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: Hemp seed oil, oral concumption, 20 ml/day for 2 months. Intervention 2: Control group: No treatment.

Treatment - Drugs

Intervention group: Hemp seed oil, oral concumption, 20 ml/day for 2 months.

Control group: No treatment

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing regular hemodialysis for at least 3 months Exclusion criteria: active infection; consuming immunosuppressive medications; autoimmune diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum concentration of interleukin-6. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit.;Serum concentration of interleukin-33. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit.	—

Secondary

Measure	Time frame
Adverse effects. Timepoint: During the study. Method of measurement: patient self report.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Sharifi Negad

Kerman University of Medical Sciences

zahrasharifi12@yahoo.com+98 34 3132 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026